Industry News
Bionomics posts maiden profit for FY14
Income from Bionomics' (ASX:BNO) licensing deal with Merck for Alzheimer's candidate BNC375 helped the company report its first post-tax operating profit for the last financial year. [ + ]
New centre to look at how the brain works
Understanding how the human brain works is the not so small task the new ARC Centre of Excellence for Integrative Brain Function is planning to tackle. [ + ]
Potential new standard of care for prostate cancer
A potential new standard of care is emerging for prostate cancer with a new treatment combination significantly reducing the spread of the disease as well as limiting side effects. [ + ]
Australian Genomic Technologies Association conference
The 14th Australasian Genomic Technologies Association (AGTA) conference will be held at the Crown Promenade, Melbourne, Australia, Sunday 12 to Wednesday 15 October 2014. [ + ]
2014 Women in Science Fellowship winners announced
The winners of the 2014 L'Oréal for Women in Science Fellowships have been announced. The fellowships provide $25,000 to early-career female scientists to support them in their specialist area of research. [ + ]
Abcam establishes a direct service for ANZ
Protein research tool provider Abcam has established a direct service to Australia and New Zealand. [ + ]
Portable blood tests for evaluating concussions
Abbott Point of Care and the US Department of Defense have announced a collaboration to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs) - a significant health concern for military service members. [ + ]
Identifying a mechanism for forming blood stem cells
Scientists from the Garvan Institute of Medical Research and Monash University have uncovered a mechanism essential for forming hematopoietic stem cells (HSCs) - a special group of cells in the early embryo that ultimately generate all the blood and immune cells in our bodies. [ + ]
Starpharma loss widens during "important" year
Starpharma put a chunk of its free cash to good use during FY14, making progress with its drug delivery, antimicrobial and agribusiness programs.
[ + ]ResMed launches new sleep breathing devices, platform
ResMed (SSX:RMD) has unveiled its new Air Solutions sleep-disordered breathing therapy platform, including the flagship AirSense 10 positive airway pressure devices.
[ + ]How natural killer cells detect and destroy
A better understanding of the how the cytotoxic lymphocytes, natural killer cells, survive and thrive will help in manipulating them to intercept cancers and other disorders.
[ + ]NHMRC reports on progress to improve clinical trials
The National Health and Medical Research Council (NHMRC), tasked with implementing a range of initiatives designed to make the process of initiating and conducting clinical trials in Australia significantly more efficient and cost effective, has reported on the progress of work under the initiative and advised it will update the information monthly.
[ + ]Hitachi Data Systems awards Intersect Australia
Hitachi Data Systems has presented eResearch support agency Intersect Australia with the APAC Health and Life Sciences Innovation Award, recognising the company's achievements in fostering collaboration, innovation and efficiencies in the medical research sector. [ + ]
ACD and Leica Biosystems co-market RNA in situ hybridisation platform
Leica Biosystems and Advanced Cell Diagnostics are co-marketing ACD's RNAscope LS ISH assays with Leica Biosystems' Bond RX research staining platform. The agreement provides researchers with an integrated and fully automated ISH solution. [ + ]
Abcam establishes direct service for ANZ
Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors, which is expected to improve delivery times and better meet researchers' needs. [ + ]